UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC CFI 698/2024

Nov 14, 2024·EP2501384: METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY

Case details
Status
Case Closed
Action
Generic
Category
Document Access (RoP262)
Parties
Respondents
Reps: Gregory Bacon (Bristows LLP); Wim Maas (Taylor Wessing)
Division
Milan CD
Judges
Technology
Organic Chemistry
Language
English
First decided
Feb 3, 2025
Decisions
  • 2025-02-03
    DismissedApplication RoP262.1 (b)

    Application by STADAPHARM GmbH for public access to case documents under R.262.1(b) RoP in the proceedings before the Milan Central Division was dismissed. The court found that STADAPHARM's primary purpose was to expose Novartis's defence strategy in order to facilitate a parallel national (Munich OLG) proceeding rather than to exercise legitimate public oversight. Access was denied as it would create undue pressure on Novartis and undermine the integrity of the proceedings. NOVARTIS's request for costs was also dismissed.

    Legal issues:Public access to court documents R.262.1(b) RoPPrimary purpose of access requestIntegrity of proceedings as limitation on access rightValidity of non-digitally signed submissions (R.4.1 RoP)
Documents
Document titleDatePublic
Case Closure Formal Check2025-04-16Not public
ORDER2025-04-11Public
Hearing-Dates2025-04-11Not public
Written-Procedure-Closure2025-04-11Not public
Hearing-Dates2025-04-11Not public
ORDER2025-04-11Public
Hearing-Dates2025-04-11Not public
Outcome of the Order2025-04-01Not public
ORDER 1st April2025-04-01Public
ORDER 1st April2025-04-01Not public
Comments on Withdrawal2025-03-31Not public
ORDER 28 MARCH 2025 WITHDRAWL APP2025-03-28Not public
Template-Order2025-03-28Not public
Receipt2025-03-28Not public
Application to withdrawal and reimbursement of Court fees2025-03-28Not public
ORDER 28 MARCH 20252025-03-28Not public
Outcome of the Order2025-03-25Not public
ORDER 25 MARCH 20252025-03-25Public
Receipt2025-03-25Not public
letter2025-03-24Not public
Receipt2025-03-12Not public
Application2025-03-11Not public
Acknowledgement-of-lodging2025-03-11Not public
Annex TW402025-03-11Not public
Annex TW432025-03-11Not public
Annex TW452025-03-11Not public
Annex TW372025-03-11Not public
Annex TW392025-03-11Not public
Annex TW382025-03-11Not public
Reply2025-03-11Not public
Annex TW412025-03-11Not public
Annex TW442025-03-11Not public
Annex TW422025-03-11Not public
Annex TW462025-03-11Not public
Formal-checks_Notification-of-positive-outcome2025-02-11Not public
Acknowledgement-of-lodging2025-02-10Not public
Annex FS172025-02-10Not public
Annex FS032025-02-10Not public
Annex FS062025-02-10Not public
Annex FS142025-02-10Not public
Annex FS162025-02-10Not public
Annex FS182025-02-10Not public
Annex FS012025-02-10Not public
Annex FS022025-02-10Not public
Annex FS092025-02-10Not public
Defence to the statement for a declaration of non-infringement2025-02-10Not public
Annex FS082025-02-10Not public
Annex FS072025-02-10Not public
Annex FS052025-02-10Not public
Annex FS132025-02-10Not public
Annex FS152025-02-10Not public
Annex FS102025-02-10Not public
Annex FS122025-02-10Not public
Annex FS042025-02-10Not public
Annex FS112025-02-10Not public
Annex FS192025-02-10Not public
Outcome of the Order2025-02-03Not public
ORDER 3rd February2025-02-03Public
Outcome of the Order2025-02-03Not public
ORDER 3rd February2025-02-03Public
Receipt2025-01-28Not public
Exhibit NVS022025-01-28Not public
Exhibit NVS012025-01-28Not public
RoP 9 Further submission of 28 January 20252025-01-28Not public
Receipt2025-01-27Not public
2025.01.24 Novartis RoP 9 procedural application in response to Stada reply2025-01-24Not public
2025 01 17 - Novartis response to Stadapharm request for access to documents2025-01-24Not public
Panel-Appointment2025-01-17Not public
Acknowledgement-of-lodging2025-01-14Not public
RgR 16.1(b) request2025-01-14Not public
Notification Of Service2024-12-20Not public
Service Receipt2024-12-20Not public
Acknowledgement of access to case2024-12-18Not public
Letter-for-Service2024-11-22Not public
Panel-Appointment2024-11-21Not public
communicationCheck2024-11-19Not public
Document from EPO2024-11-19Not public
EPO-Request-for-case-pending2024-11-15Not public
Acknowledgement-of-lodging2024-11-15Not public
Formal-checks_Notification-of-positive-outcome2024-11-15Not public
Annex TW142024-11-14Not public
Annex TW222024-11-14Not public
Annex TW102024-11-14Not public
Annex TW172024-11-14Not public
Annex TW342024-11-14Not public
Annex TW122024-11-14Not public
Annex TW132024-11-14Not public
Annex TW312024-11-14Not public
Annex TW012024-11-14Not public
Annex TW152024-11-14Not public
Annex TW032024-11-14Not public
Annex TW212024-11-14Not public
Annex TW202024-11-14Not public
Annex TW302024-11-14Not public
Annex TW252024-11-14Not public
Annex TW282024-11-14Not public
Annex TW072024-11-14Not public
Statement of claim DNI2024-11-14Not public
Annex TW182024-11-14Not public
Annex TW092024-11-14Not public
Annex TW332024-11-14Not public
Annex TW272024-11-14Not public
Annex TW322024-11-14Not public
Annex TW232024-11-14Not public
Annex TW112024-11-14Not public
Annex TW352024-11-14Not public
Annex TW022024-11-14Not public
Annex TW242024-11-14Not public
Statement of claim DNI2024-11-14Not public
Annex TW362024-11-14Not public
Annex TW042024-11-14Not public
Annex TW162024-11-14Not public
Annex TW292024-11-14Not public
Annex TW052024-11-14Not public
Annex TW262024-11-14Not public
Annex TW192024-11-14Not public
Annex TW062024-11-14Not public
Annex TW082024-11-14Not public